1 |
orthogonal projections to latent structures
(83 times)
|
Chemistry Techniques, Analytical (15 times)
|
PCA (33 times) NMR (9 times) PLS (9 times)
|
2006 [Application of O-PLS in fundamental study of non-invasive measurement of human blood glucose concentration with near infrared spectroscopy].
|
2 |
orthogonal partial least squares
(70 times)
|
Chemistry Techniques, Analytical (16 times)
|
PCA (13 times) GC-MS (6 times) PLS (6 times)
|
2008 Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice.
|
3 |
optimized potentials for liquid simulations
(26 times)
|
Chemistry (20 times)
|
MD (5 times) GAFF (4 times) AMBER (2 times)
|
1988 The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.
|
4 |
orthogonal partial least squares analysis
(11 times)
|
Pharmacology (3 times)
|
PCA (4 times) PLS-DA (3 times) LC-Q-TOF-MS (2 times)
|
2008 Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites.
|
5 |
orthogonal partial least squares to latent structures
(9 times)
|
Diagnostic Imaging (3 times)
|
AD (9 times) MCI (6 times) MRI (6 times)
|
2010 Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.
|
6 |
orthogonal PLS
(9 times)
|
Computational Biology (2 times)
|
PCA (7 times) PLS (7 times) ALZ (1 time)
|
2007 Chemometrics in metabonomics.
|
7 |
O-phospho-L-serine
(6 times)
|
Pharmacology (5 times)
|
FVIII (3 times) BDDrFVIII (1 time) BMDCs (1 time)
|
1984 Antagonist activity of phosphorus-containing glutamate analogues in the perforant path.
|
8 |
open partial laryngeal surgery
(2 times)
|
Otolaryngology (1 time)
|
DSS (1 time) LC (1 time) OS (1 time)
|
2018 Nomograms for prediction of postoperative complications in open partial laryngeal surgery.
|
9 |
Optimized Potentials for Liquid State
(1 time)
|
Chemistry (1 time)
|
TraPPE-UA (1 time)
|
2012 Aqueous tert-butanol mixtures: a model for molecular-emulsions.
|
10 |
Orion's pragmatic language skills checklist
(1 time)
|
Psychology (1 time)
|
OCD (1 time)
|
2016 Pragmatic Competency and Obsessive-Compulsive Disorder: A Comparative Assessment with Normal Controls.
|
11 |
ortho-phospho-L-serine
(1 time)
|
Biotechnology (1 time)
|
FVIII (1 time) PS (1 time) rFVIII (1 time)
|
2011 Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
|
12 |
Orthogonal Partial least squares discriminant analysis
(1 time)
|
Vascular Diseases (1 time)
|
NMR (1 time)
|
2016 Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis.
|
13 |
orthogonal partial least squares-discriminant
(1 time)
|
Vascular Diseases (1 time)
|
---
|
2016 Plasma metabolomic profile in fibrosing pulmonary sarcoidosis.
|
14 |
orthogonal projection to latent structures by partial least square
(1 time)
|
Vascular Diseases (1 time)
|
CMR (1 time) ECV (1 time) HHD (1 time)
|
2018 Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease.
|
15 |
orthogonal projection to latent structures-discriminant analysis
(1 time)
|
Proteome (1 time)
|
PCA (1 time) UPLC-MS (1 time)
|
2016 Soft Corals Biodiversity in the Egyptian Red Sea: A Comparative MS and NMR Metabolomics Approach of Wild and Aquarium Grown Species.
|
16 |
Orthogonal projection to the least square analysis
(1 time)
|
Social Sciences (1 time)
|
VIP (1 time)
|
2013 NMR metabolomics for identification of adenosine A1 receptor binding compounds from Boesenbergia rotunda rhizomes extract.
|
17 |
orthogonal signal correction partial least square discrimination
(1 time)
|
|
LMA (1 time) TCM (1 time)
|
2019 Screening and Identification of Antipyretic Components in the Postfrost Leaves of Morus alba Based on Multivariable and Continuous-Index Spectrum-Effect Correlation.
|
18 |
VIII-O-Phospho-L-Serine
(1 time)
|
Pharmacology (1 time)
|
FVIII (1 time) NAbs (1 time)
|
2014 Intravenous administration of Factor VIII-O-Phospho-L-Serine (OPLS) complex reduces immunogenicity and preserves pharmacokinetics of the therapeutic protein.
|